Advisors Asset Management Inc. cut its stake in shares of Cantel Medical Corp. (NYSE:CMD) by 33.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,539 shares of the company’s stock after selling 14,032 shares during the period. Advisors Asset Management Inc. owned about 0.07% of Cantel Medical worth $2,593,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in Cantel Medical during the second quarter valued at $376,271,000. Vanguard Group Inc. purchased a new position in Cantel Medical during the second quarter valued at $246,860,000. Neuberger Berman Group LLC purchased a new position in Cantel Medical during the second quarter valued at $96,236,000. Dimensional Fund Advisors LP purchased a new position in Cantel Medical during the second quarter valued at $75,756,000. Finally, Wells Fargo & Company MN purchased a new position in Cantel Medical during the second quarter valued at $75,715,000. Institutional investors own 84.98% of the company’s stock.
Cantel Medical Corp. (NYSE:CMD) opened at $103.38 on Tuesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.41 and a quick ratio of 1.49. The company has a market capitalization of $4,451.49, a PE ratio of 51.19 and a beta of 1.24. Cantel Medical Corp. has a 52-week low of $69.21 and a 52-week high of $108.00.
Cantel Medical (NYSE:CMD) last posted its earnings results on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.02. The company had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. Cantel Medical’s quarterly revenue was up 14.8% compared to the same quarter last year. sell-side analysts predict that Cantel Medical Corp. will post 2.34 EPS for the current fiscal year.
The company also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be given a $0.085 dividend. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 16th. Cantel Medical’s payout ratio is currently 8.19%.
In other Cantel Medical news, Director George L. Fotiades sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, October 13th. The stock was sold at an average price of $95.23, for a total transaction of $571,380.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Eric W. Nodiff sold 2,868 shares of the business’s stock in a transaction that occurred on Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the sale, the executive vice president now directly owns 39,102 shares in the company, valued at $3,814,400.10. The disclosure for this sale can be found here. Insiders sold 36,368 shares of company stock worth $3,576,028 over the last quarter. 12.30% of the stock is owned by company insiders.
Several brokerages have recently commented on CMD. Needham & Company LLC restated a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Zacks Investment Research upgraded Cantel Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $91.67.
WARNING: “Advisors Asset Management Inc. Has $2.59 Million Holdings in Cantel Medical Corp. (NYSE:CMD)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/05/advisors-asset-management-inc-reduces-stake-in-cantel-medical-corp-cmd.html.
About Cantel Medical
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.